Lyophilization

Shorten Time to Market with New Data-Driven Lyophilization Process

Jeff Tremain

AbbVie Contract Manufacturing

Clinical Trial Logistics

Innovative Strategies to Maintain Product Integrity in Biologic and Biosimilar Clinical Studies

Mark Woolf

Catalent

Business Development

Q: How are you growing your business development activities in the absence of conventional trade shows and other traditional business development/marketing activities?

Pharma's Almanac

COVID-19 Impacts

Q: Putting aside COVID-19 vaccines and therapeutics, what do you think will be the most significant development in the industry in 2021?

Pharma's Almanac

Tissue Models

Accurately Recapitulating Environmental Niches in In Vitro Models of the Intestine

Liz Boazak, Ph.D.

Altis Biosystems

Facility Design

Cell Therapy Facility Design Synopsis: Horizontal vs. Vertical

Brian Peasley

IPS-Integrated Project Services, LLC

Tissue Models

Developing a Robust In Vitro Intestinal Model for Preclinical Candidate Screening of GI Toxicity

Ron Laethem, Ph.D.

Altis Biosystems

Process Intensification

Factory of the Future Will Be a Convergence of Digital and Bioprocessing Technologies

Vikas Revankar

MilliporeSigma

Nitrosamine

Supporting Drug Manufacturers with Emprove® Nitrosamine Declarations

Ulrich Reichert, M.D.R.A.

MilliporeSigma

Chemistry, Manufacturing, and Controls

Phase-Appropriate CMC Activities Facilitate the Transition from Early Development through Commercialization

Matthew Rota; Lisa Caralli; Jim Spavins

Catalent

Cell Therapy

Economically Viable, Same-Day Autologous Cell Therapies

Gregory Frost, Ph.D.; Sid Kerkar, M.D.

EXUMA Biotechnology

Tissue Models

Recapitulating the Multifaceted Inflammatory Environment of the Intestine In Vitro

Bailey Zwarycz, Ph.D

Altis Biosystems

Process Development

Innovative Approach to Process Development

Gerhard Noessner, Ph.D.

Fareva

Gene Therapy

Beyond 2020: Looking into the Crystal Ball for Gene Therapy

Ratish Krishnan

MilliporeSigma

Tissue Models

The Power of RepliGut In Vitro Intestinal Stem Cell Models

Bailey Zwarycz, Ph.D

Altis Biosystems

HPAPI

A Successful Approach for Managing Unexpected Increases in Potency for HPAPIs

Daniela Kovats

Fareva

Cell Therapy

Allogeneic T Cell Therapies: Efficient Commercial Manufacturing Readiness using “Manufacturing by Design” Methodology

Catalent